AI assistant
MERIT MEDICAL SYSTEMS INC — Director's Dealing 2021
Sep 10, 2021
31049_dirs_2021-09-10_80403c72-998b-40a0-a637-312daf1f92fd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2021-09-08
Reporting Person: LAMPROPOULOS FRED P (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-08 | Common Stock, No Par Value | M | 5000 | $17.27 | Acquired | 6269 | Indirect |
| 2021-09-08 | Common Stock, No Par Value | F | 2410 | $72.23 | Disposed | 3859 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-08 | Non-qualified stock options (right to buy) | $17.27 | M | 5000 | Disposed | 2022-02-13 | Common Stock (5000) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, No Par Value | 967916 | Direct |
| Common Stock, No Par Value | 95919 | Indirect |
| Common Stock, No Par Value | 90 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified stock options (right to buy) | $16.05 | 2023-01-28 | Common Stock (50000) | 50000 | Direct |
| Non-qualified stock options (right to buy) | $16.05 | 2023-01-28 | Common Stock (6000) | 6000 | Indirect |
| Non-qualified stock options (right to buy) | $28.20 | 2024-04-14 | Common Stock (200000) | 200000 | Direct |
| Non-qualified stock options (right to buy) | $28.20 | 2024-04-14 | Common Stock (6000) | 6000 | Indirect |
| Non-qualified stock options (right to buy) | $44.80 | 2025-03-02 | Common Stock (38002) | 38002 | Direct |
| Non-qualified stock options (right to buy) | $44.80 | 2025-03-02 | Common Stock (4000) | 4000 | Indirect |
| Non-qualified stock options (right to buy) | $55.73 | 2026-03-01 | Common Stock (159151) | 159151 | Direct |
| Non-qualified stock options (right to buy) | $55.73 | 2026-03-01 | Common Stock (2000) | 2000 | Indirect |
| Non-qualified stock options (right to buy) | $37.71 | 2027-02-26 | Common Stock (100334) | 100334 | Direct |
| Non-qualified stock options (right to buy) | $56.25 | 2028-03-19 | Common Stock (58083) | 58083 | Direct |
Footnotes
F1: Represents securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse.
F2: Represents plan holdings as of 9/10/2021.
F3: Became exercisable in equal annual installments of 20% commencing 2/13/2016.
F4: Became exercisable in equal annual installments of 20% commencing 1/28/2017.
F5: Original grant of 7,500 options was to become vested and exercisable in equal annual installments of 20% commencing 1/28/2017. Options not vested as of 6/22/2020 have been forfeited.
F6: Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.
F7: Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 4/14/2018. Options not vested as of 6/22/2020 have been forfeited.
F8: Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
F9: Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited.
F10: Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
F11: Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
F12: Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
F13: Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.